Keyphrases
Adenovirus
100%
Pancreatic β-cells
100%
Double Strand
100%
Serotype 8
100%
Virus Serotype
100%
Streptozotocin-induced Diabetes
100%
Glucagon-like
100%
Insulin
25%
B Cells
25%
Diabetes Management
16%
Streptozotocin
16%
β-cell Proliferation
16%
Novel Therapeutics
8%
Diabetes
8%
Biological Activity
8%
Intraperitoneal Delivery
8%
Incretin Hormones
8%
β-cell Dysfunction
8%
Biologically Active
8%
Glucose Tolerance
8%
Intraperitoneal Injection
8%
Receptor Agonist
8%
Circulating Levels
8%
Glucose-stimulated Insulin Secretion
8%
Luciferase
8%
A1 Receptor
8%
Insulin Gene Expression
8%
Long-term Transgene Expression
8%
Glucose Injection
8%
β-Cell Survival
8%
MIN6 Cells
8%
Biological Half-life
8%
PCNA Expression
8%
Antidiabetic Action
8%
Active Research
8%
Peptide-based Therapeutics
8%
Medicine and Dentistry
Beta Cell
100%
Adeno-Associated Virus
100%
Glucagon Like Peptide 1
100%
Streptozotocin-Induced Diabetes Mellitus
100%
Serotype
100%
Diabetes
27%
Promoter Region
27%
Transgene
27%
Low Drug Dose
18%
Secretion (Process)
18%
Cell Proliferation
18%
Streptozocin
18%
Insulin Release
9%
Cell Survival
9%
Gene Expression
9%
Cell Damage
9%
Upregulation
9%
Bioassay
9%
Intraperitoneal Drug Administration
9%
Glucose Tolerance
9%
Glucagon-Like Peptide-1 Agonist
9%
Antidiabetic Activity
9%
Luciferase
9%
Incretin
9%
Biological Activity
9%
Biochemistry, Genetics and Molecular Biology
Adeno Associated Virus
100%
Serotype
100%
Streptozotocin
100%
Glucagon-Like Peptide-1
100%
Transgene
27%
Promoter Region
27%
Secretion (Process)
18%
Cell Proliferation
18%
Low Drug Dose
18%
Gene Expression
9%
Insulin Release
9%
Cell Survival
9%
Upregulation
9%
Receptor Agonists
9%
Antidiabetic Activity
9%
Luciferase
9%
Cell Damage
9%
Glucagon-Like Peptide 1 Receptor
9%
Incretin
9%
Biological Activity
9%
Immunology and Microbiology
Serotype
100%
Adeno Associated Virus
100%
Glucagon-Like Peptide-1
100%
Insulin
33%
Promoter Region
25%
Transgene
25%
Secretion (Process)
16%
Low Drug Dose
16%
Cell Proliferation
16%
Agonist
8%
Insulin Release
8%
Cell Survival
8%
Gene Expression
8%
Upregulation
8%
Antidiabetic Activity
8%
Cell Damage
8%
Biological Activity
8%
Peptides
8%
Incretin
8%
Pharmacology, Toxicology and Pharmaceutical Science
Adeno Associated Virus
100%
Streptozotocin-Induced Diabetes Mellitus
100%
Glucagon-Like Peptide-1
100%
Streptozotocin
18%
Biological Activity
9%
Biological Half-Life
9%
Glucagon Like Peptide 1 Receptor Agonist
9%
Intraperitoneal Injection
9%
Luciferase
9%
Incretin
9%